Prognosis and fertility of stage II to IV borderline ovarian tumors after fertility-sparing surgery

Guo Zheng(Zhengzhou University), Ruixia Guo(Shanghai Ninth People's Hospital), Lin Si(Zhengzhou University), Mengling Zhao(First Affiliated Hospital of Zhengzhou University), Qian Wang(Dongbei University of Finance and Economics), Meng Mao(Guiyang Medical University), Hanlin Fu(First Affiliated Hospital of Zhengzhou University), Danxia Chu(Zhengzhou University), Zhang Ye(Inner Mongolia Medical University), Tianjiao Lai(First Affiliated Hospital of Zhengzhou University)
International Journal of Gynecological Cancer
February 5, 2025
10.1016/j.ijgc.2025.101666
Cited by 1

Related Papers

A Lancet Commission on 70 years of women's reproductive, maternal, newborn, child, and adolescent health in China
|The Lancet|2021|579
Burosumab Therapy in Children with X-Linked Hypophosphatemia
|New England Journal of Medicine|2018|479
Prevalence of Autism Spectrum Disorder in China: A Nationwide Multi-center Population-based Study Among Children Aged 6 to 12 Years
|Neuroscience Bulletin|2020|468
Olig2 Targets Chromatin Remodelers to Enhancers to Initiate Oligodendrocyte Differentiation
|Cell|2013|384
Burosumab versus conventional therapy in children with X-linked hypophosphataemia: a randomised, active-controlled, open-label, phase 3 trial
|The Lancet|2019|375